Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03085680 · ClinicalTrials.gov registry record · Phase 2
Curcumin and Function in Older Adults
A Phase 2 study of Older Adults and Cognitive Function, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT03085680: Completed Phase 2 study of Older Adults and Cognitive Function, sponsored by University of Florida.
NCT03085680 is a Phase 2 study of Older Adults and Cognitive Function that has completed, run by University of Florida. The registered enrollment target is 17 participants, below the 224-participant average among 23 other Older Adults trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03085680, a Phase 2 study of Older Adults and Cognitive Function, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
This placebo-controlled RCT tests whether dietary supplementation with curcumin maintains or improves cognitive and physical function in older adults who are at high risk of functional decline due existing (mild) functional impairments and elevated biomarkers of inflammation and explore the association between functional changes and changes in biological indicators of active inflammation.
Primary Outcome
To examine the effects of dietary supplementation with curcumin on changes in physical function walking speed- 400meter walk test.
Conditions Studied
Interventions
- DRUG Curcumin
- DRUG microcrystalline cellulose
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-08-11 |
| Est. Completion | 2019-10-18 |
| Phase | Phase 2 |
What the finished NCT03085680 record still lists
NCT03085680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 224-participant average among 23 other Older Adults trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Older Adults appearing as the primary indexed condition, and to 2 interventions - of which Curcumin is the first listed.
NCT03085680 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03085680 about?
NCT03085680 is a clinical study titled "Curcumin and Function in Older Adults". This placebo-controlled RCT tests whether dietary supplementation with curcumin maintains or improves cognitive and physical function in older adults who are at high risk of functional decline due existing (mild) functional impairments and elevated biomarkers of inflammation and explore the associat...
What is the current status of trial NCT03085680?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2017-08-11. Estimated completion is 2019-10-18.
What conditions does trial NCT03085680 study?
This clinical trial studies the following conditions: Older Adults, Cognitive Function, Physical Function.
What interventions are being tested in trial NCT03085680?
The interventions under investigation include: Curcumin (DRUG), microcrystalline cellulose (DRUG).
Who is sponsoring clinical trial NCT03085680?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03085680 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Older Adults
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03085680's enrollment target sits among peer trials
17 22nd of 23 higher than 1 of 23 other Older Adults trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Older Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
RECRUITING · Phase 2
-
Oral vs IV Sedation for Cataract Surgery in Older Adults
RECRUITING · Phase 4
-
Improving Needs Among Older Adults
RECRUITING · NA
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
A Pilot Randomized Controlled Trial of the Hopeful and Healthy Living Program
RECRUITING · NA
-
Building Resilience for Surgical Recovery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI